Joseph Steinberg, MD
Urology · Morristown, NJNPI 1659367209
Payments from drug & device makers
Across 135 payments — averaging $68.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EDAP Technomed Inc$5K
- Angiodynamics, Inc.$2K
- Sumitomo Pharma America, Inc.$347
- Astellas Pharma US Inc$341
- Procept Biorobotics Corporation$194
- AbbVie$125
- plus $1K from 36 others
What the payments were for
- Consulting fees$4,50049%
- Travel & lodging$8029%
- Food & beverage$3,75441%
- Education$2062%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EDAP Technomed Inc | 8 | $4,887 |
| Angiodynamics, Inc. | 11 | $1,971 |
| Sumitomo Pharma America, Inc. | 20 | $347 |
| Astellas Pharma US Inc | 15 | $341 |
| Procept Biorobotics Corporation | 2 | $194 |
| AbbVie | 6 | $125 |
| Medtronic | 1 | $125 |
| Johnson & Johnson(2 entities) | 6 | $116 |
| Myovant Sciences Inc. | 6 | $104 |
| Urogen Pharma, Inc. | 6 | $99 |
| Telix Pharmaceuticals | 5 | $85 |
| Bayer | 4 | $71 |
| Urovant Sciences Inc | 5 | $71 |
| Coloplast | 3 | $66 |
| Boston Scientific | 3 | $47 |
| Agiliti Surgical, Inc. | 1 | $47 |
| BD | 1 | $44 |
| Mimedx Group, Inc. | 2 | $40 |
| 180 Medical, Inc. | 2 | $36 |
| AstraZeneca | 1 | $35 |
| Endo USA, Inc. | 2 | $35 |
| Myriad Genetic Laboratories, Inc. | 2 | $33 |
| Endo Pharmaceuticals Inc. | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Ferring Pharmaceuticals Inc. | 2 | $28 |
| Kowa Pharmaceuticals America, Inc. | 1 | $26 |
| Tolmar, Inc. | 1 | $19 |
| Immunitybio, Inc. | 1 | $19 |
| Intuitive Surgical | 1 | $18 |
| Photocure Inc | 1 | $16 |
| Olympus America Inc. | 1 | $16 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $16 |
| ABC Home Medical Supply, Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Tolmar Pharmaceuticals, Inc. | 1 | $15 |
| GSK | 1 | $15 |
| Zyla Life Sciences, Inc. | 1 | $14 |
| Pfizer | 1 | $14 |
| Avation Medical, Inc. | 1 | $13 |
| Bioprotect Medical, Inc. | 1 | $13 |
| Eisai Inc. | 1 | $11 |
| Travere Therapeutics, Inc. | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FOCAL ONE$4,500
- Nanoknife$1,729
- AquaBeam Robotic System$171
- INTERSTIM$125
How this compares
$9,262 in reported general payments places this provider in the 80th percentile of 401 urology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Thiola EcTiopronin | 12 | $183,161 |
| MyrbetriqMirabegron | 190 | $168,753 |
| GemtesaVibegron | 134 | $105,431 |
| Tamsulosin Hcl | 1,140 | $23,961 |
| Finasteride | 795 | $11,243 |
| Mirabegron ErMirabegron | 11 | $8,209 |
| Potassium Citrate ErPotassium Citrate | 30 | $4,694 |
| Silodosin | 57 | $4,662 |
| Dutasteride | 116 | $4,458 |
| Oxybutynin Chloride ErOxybutynin Chloride | 130 | $3,407 |
| Tadalafil | 14 | $3,281 |
| Estradiol | 16 | $1,299 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 52 | $1,004 |
| Oxybutynin Chloride | 53 | $751 |
| Solifenacin Succinate | 13 | $596 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $341 | $168,753190 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $347 | $105,431134 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 401 urology providers in New Jersey.
Other urology in Morristown
- David TaylorMorristown$68K
- David ChaikinMorristown$65K
- Arthur IsraelMorristown$59K
- Benjamin TaylorMorristown$37K
- Anika AckermanMorristown$25K
- Gordon BrownCherry Hill$2.8M
- Nitin YerramHackensack$1.6M
- Michael StifelmanHackensack$1.5M
- Thomas MuellerLinwood$1.2M
- David SussmanLinwood$833K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.